Literature DB >> 15036710

Uterine rupture associated with misoprostol labor induction in women with previous cesarean delivery.

Halil Aslan1, Emine Unlu, Mehmet Agar, Yavuz Ceylan.   

Abstract

OBJECTIVE: To review our experience with uterine rupture in patients undergoing a trial of labor with a history of previous cesarean delivery in which labor was induced with misoprostol. STUDY
DESIGN: A retrospective chart review was used to select patients who underwent induction of labor with misoprostol during the period from February 1999 to June 2002. Women with a history of cesarean delivery were retrospectively compared with those without uterine scarring.
RESULTS: Uterine rupture occurred in 4 of 41 patients with previous cesarean delivery who had labor induced with misoprostol. The rate of uterine rupture (9.7%) was significantly higher in patients with a previous cesarean delivery (P<0.001). No uterine rupture occurred in 50 patients without uterine scarring. Women with a history of cesarean delivery were more likely to have oxytocin augmentation than those without uterine scarring (41% versus 20%; P=0.037).
CONCLUSION: Misoprostol induction of labor increases the risk of uterine rupture in women with a history of cesarean delivery.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15036710     DOI: 10.1016/S0301-2115(03)00363-4

Source DB:  PubMed          Journal:  Eur J Obstet Gynecol Reprod Biol        ISSN: 0301-2115            Impact factor:   2.435


  10 in total

1.  Mode of delivery in women with antepartum fetal death and prior cesarean delivery.

Authors:  Mildred M Ramirez; Sharon Gilbert; Mark B Landon; Dwight J Rouse; Catherine Y Spong; Michael W Varner; Steve N Caritis; Ronald J Wapner; Yoram Sorokin; Menachem Miodovnik; Marshall Carpenter; Alan M Peaceman; Mary J O'Sullivan; Baha M Sibai; Oded Langer; John M Thorp; Brian M Mercer
Journal:  Am J Perinatol       Date:  2010-05-19       Impact factor: 1.862

Review 2.  Misoprostol for Labour Induction after Previous Caesarean Section - Forever a "No Go"?

Authors:  W Rath; P Tsikouras
Journal:  Geburtshilfe Frauenheilkd       Date:  2015-11       Impact factor: 2.915

3.  Intracervical double-balloon catheter versus dinoprostone for cervical ripening in labor induction in pregnancies with a high risk of uterine hyperstimulation.

Authors:  Javier Vega Cañadas; María Teulón González; Natalia Pagola Limón; María Sanz Alguacil; María García-Luján Prieto; Rocío Canete Riaza; Rosa Montero-Macías
Journal:  Arch Gynecol Obstet       Date:  2021-04-27       Impact factor: 2.344

Review 4.  Oral misoprostol for induction of labour.

Authors:  Zarko Alfirevic; Nasreen Aflaifel; Andrew Weeks
Journal:  Cochrane Database Syst Rev       Date:  2014-06-13

5.  Does feticide shorten termination duration in second trimester pregnancy terminations?

Authors:  Aytek Şık; Sedat Bilecan; Serkan Kumbasar; Yaşam Kemal Akpak; Yilda Arzu Aba
Journal:  Afr Health Sci       Date:  2019-03       Impact factor: 0.927

6.  Ruptured uterus: Frequency, risk factors and feto-maternal outcome: Current scenario in a low-resource setup.

Authors:  Saida Abrar; Tahira Abrar; Ehsan Sayyed; Sidra Ali Naqvi
Journal:  PLoS One       Date:  2022-04-08       Impact factor: 3.240

Review 7.  Forensic Toxicological Aspects of Misoprostol Use in Pharmacological Abortions.

Authors:  Paweł Szpot; Olga Wachełko; Marcin Zawadzki
Journal:  Molecules       Date:  2022-10-03       Impact factor: 4.927

8.  Low-dose oral misoprostol for induction of labour.

Authors:  Robbie S Kerr; Nimisha Kumar; Myfanwy J Williams; Anna Cuthbert; Nasreen Aflaifel; David M Haas; Andrew D Weeks
Journal:  Cochrane Database Syst Rev       Date:  2021-06-22

Review 9.  A critical appraisal of the misoprostol removable, controlled-release vaginal delivery system of labor induction.

Authors:  Charlotte Patte; Philippe Deruelle
Journal:  Int J Womens Health       Date:  2015-11-12

10.  Induction of labor after one previous Cesarean section in women with an unfavorable cervix: A retrospective cohort study.

Authors:  Tove Wallstrom; Jenny Bjorklund; Joanna Frykman; Hans Jarnbert-Pettersson; Helena Akerud; Elisabeth Darj; Kristina Gemzell-Danielsson; Eva Wiberg-Itzel
Journal:  PLoS One       Date:  2018-07-02       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.